INIS (Radnostix) Cyclically Adjusted PB Ratio: (As of Jul. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Radnostix Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Radnostix  (OTCPK:INIS) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Radnostix Cyclically Adjusted PB Ratio Related Terms


Radnostix Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Radnostix's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Radnostix Cyclically Adjusted PB Ratio Chart

Radnostix Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.65 6.00 8.73 8.68 18.31

Radnostix Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.78 21.38 16.64 18.31 25.31

INIS vs SCYX, BTAI, IXHL: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Radnostix's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Radnostix Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Radnostix's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Radnostix's Cyclically Adjusted PB Ratio falls into.



Radnostix Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Radnostix's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Radnostix's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.005/330.2130*330.2130
=0.005

Current CPI (Mar. 2026) = 330.2130.

Radnostix Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.007 241.018 0.010
201609 0.006 241.428 0.008
201612 0.004 241.432 0.005
201703 0.004 243.801 0.005
201706 0.002 244.955 0.003
201709 -0.001 246.819 -0.001
201712 -0.003 246.524 -0.004
201803 -0.002 249.554 -0.003
201806 -0.003 251.989 -0.004
201809 -0.003 252.439 -0.004
201812 -0.004 251.233 -0.005
201903 -0.003 254.202 -0.004
201906 -0.006 256.143 -0.008
201909 -0.005 256.759 -0.006
201912 -0.005 256.974 -0.006
202003 -0.005 258.115 -0.006
202006 -0.004 257.797 -0.005
202009 -0.004 260.280 -0.005
202012 0.001 260.474 0.001
202103 0.001 264.877 0.001
202106 0.001 271.696 0.001
202109 0.005 274.310 0.006
202112 0.005 278.802 0.006
202203 0.009 287.504 0.010
202206 0.010 296.311 0.011
202209 0.009 296.808 0.010
202212 0.008 296.797 0.009
202303 0.009 301.836 0.010
202306 0.008 305.109 0.009
202309 0.008 307.789 0.009
202312 0.008 306.746 0.009
202403 0.008 312.332 0.008
202406 0.007 314.175 0.007
202409 0.008 315.301 0.008
202412 0.008 315.605 0.008
202503 0.008 319.799 0.008
202506 0.008 322.561 0.008
202509 0.008 324.800 0.008
202512 0.007 324.054 0.007
202603 0.005 330.213 0.005

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Radnostix Business Description

Address 4137 Commerce Circle, Idaho Falls, ID, USA, 83401
Radnostix Inc manufactures a wide range of radioisotope-focused products used in a variety of medical and industrial applications. The company produces generic sodium iodide I-131 drug product, produces a variety of cobalt-60 products, and is in development to manufacture and sell medical devices for the nuclear medicine industry. Its business consists of five reportable segments, which include: Theranostics Products, Cobalt Products, Calibration & Reference Products, Medical Devices, and Fluorine Products. The majority of the revenue is derived from the Theranostics Products segment, which produces and distributes various isotopically pure radiopharmaceuticals, APIs, and radiochemicals for medical, industrial, and research applications.